Clinical Evidence

Clinical Validation Pathway

Building Evidence for Infant-Specific Nutrition. Auralis is developing a clinical validation pathway designed to evaluate how personalized microbiome-supportive formulation may influence tolerance, microbial balance, nutrient utilization, and developmental resilience in early life.

Clinical Rationale for Formulation

Auralis is designed to address key microbiome- and nutrition-related functions that are critical in early life and shaped by clinical evidence.

Microbiome Diversity

Supports a balanced gut microbiome, enriched with Bifidobacterium and Lactobacillus — the foundational species associated with healthy infant development.

Functional Productivity

Promotes beneficial microbial functions such as vitamin synthesis and mineral handling — critical metabolic activities that support overall nutrition.

Nutrient Utilization

Aims to enhance the bioavailability and absorption of key nutrients, including vitamins and minerals, by aligning formulation with the infant's biological profile.

Developmental Resilience

Addresses early-life nutritional factors linked to gut, immune, and neurodevelopmental outcomes — building a stronger biological foundation from the start.

From Nutrition Inputs to Lifelong Health Impact

A dynamic ecosystem — from inputs to long-term resilience.

Auralis is being developed to support the infant microbiome as a dynamic ecosystem — from nutritional inputs and microbial activation to systemic outcomes and long-term developmental resilience.

Every Auralis formula is developed within a structured regulatory framework aligned with FDA and EMA standards for infant nutrition safety. Our formulation process follows GMP-certified protocols, HACCP risk management, and EFSA-aligned ingredient safety requirements — the same rigorous standards applied to clinical-grade nutritional products.

From ingredient sourcing to final batch release, every step is traceable, tested, and compliant with the strictest international regulatory expectations for infant health.

Infant Microbiome Ecosystem — 6 surrounding nodes (Nutrition Inputs, Microbiome Activation, Functional Productivity, Systemic Outcomes, Developmental Support, Lifelong Value) Infant Microbiome Ecosystem Nutrition Inputs Microbiome Activation Functional Productivity Systemic Outcomes Developmental Support Lifelong Value
Validation Pathway

Four stages of clinical validation.

  1. Feasibility Studies

    Initial assessments of tolerance and acceptance of the formulation across diverse infant populations.

  2. Tolerance & Safety Monitoring

    Ongoing evaluation of gastrointestinal comfort events, ensuring safety at every stage.

  3. Microbiome Response Tracking

    Measurement of shifts in beneficial bacteria and microbial activity following personalized formulation.

  4. Development-Relevant Outcomes

    Exploration of growth, immune markers, and early neurodevelopmental signals.

Expected Health Impact

What we expect Auralis to support.

  • Improved microbial balance, with enrichment of Bifidobacterium and Lactobacillus
  • Enhanced vitamin-associated microbial functions
  • Better mineral handling and bioavailability
  • Support for gut, immune, and neurodevelopmental outcomes
  • Better digestive comfort, feeding tolerance, and day-to-day infant well-being
  • Stronger support for immune development, nutrient absorption, and healthy growth
  • Long-term health benefits with the potential to reduce complications and hospitalizations
Evidence Generation Model

A continuous clinical learning loop.

Auralis's evidence generation model is designed for continuous improvement. By collecting longitudinal data, tracking biomarkers, and feeding results back into formula refinement, the system creates a clinical learning loop that strengthens the science with every infant served.

  1. Longitudinal Data Collection

    Ongoing collection of microbiome and developmental data across the infant journey.

  2. Biomarker Tracking

    Tracking biological markers that reflect microbiome health and nutritional response.

  3. Formula Refinement Over Time

    Insights are integrated into ongoing formula iteration and improvement.

  4. Clinical Learning Loop

    Outcomes inform future personalization, strengthening the science with every infant.

Explore the Auralis Clinical Platform Learn More